Director, Transplant Immunotherapy Program
Cedars-Sinai Medical Center
Los Angeles, California
Ashley Vo, PharmD, FAST, is the administrative director of the Transplant Immunotherapy Program at CSMC and a professor of Pediatrics at the David Geffen School of Medicine at UCLA. Dr. Vo earned her PharmD degree at the University of Southern California. She completed a general practice residency and a specialty residency in administration, both at Cedars-Sinai Medical Center.
Dr. Vo’s research has been in advancing the field of desensitization for the highly HLA sensitized patients awaiting kidney transplantation. Patients, nationally and internationally, are referred to the Kidney Transplant Immunotherapy Program for desensitization and for transplantation.
Dr. Vo directs the clinical research group for all kidney transplant IIT and industry sponsored trials. She also serves as reviewer for Transplantation, American Journal of Transplantation, and Clinical Transplantation and has published in peer-reviewed journals, including the New England Journal of Medicine, Transplantation, American Journal of Transplantation. Dr. Vo has been awarded both the AST Clinician of Distinction Award, a prestigious award that recognizes clinical excellence and creative scholarship to the field of transplantation, and the Fellow of the American Society of Transplant Award.
Thursday, October 9, 2025
8:00 AM - 9:30 AM US EDT
Thursday, October 9, 2025
8:00 AM - 8:45 AM US EDT
Plenary IV: Advances in Transplanting Sensitized Patients
Thursday, October 9, 2025
4:15 PM - 5:45 PM US EDT
Emerging Therapeutics Targeting Plasma Cell Directed Therapies for Desensitization
Thursday, October 9, 2025
5:15 PM - 5:45 PM US EDT